• Explore /
  • Poster
  • / ALEXANDRA/IMpassion030: A phase 3 study of standard adjuvant chemotherapy with or without atezolizumab in patients with early-stage triple-negative breast cancer.

ALEXANDRA/IMpassion030: A phase 3 study of standard adjuvant chemotherapy with or without atezolizumab in patients with early-stage triple-negative breast cancer.

Abstract Video & Slides Poster

Authors

null

Shigehira Saji

Fukushima Medical University School of Medicine, Fukushima, Japan

Shigehira Saji , Heather L. McArthur , Michail Ignatiadis , Andrew Bailey , Sarra El-Abed , Mariana Brandao , Otto Metzger , Catherine Lai , Sebastien Guillaume , Debora Fumagalli , Dominique Agbor-tarh , Aicha Seiller , Rosa Altarcheh Xifro , Vanessa Honvault , Giuseppe Viale , Carter DuFrane , Teresa Barata , Eric P. Winer , Richard D. Gelber , Martine J. Piccart-Gebhart

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT03498716

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS597)

DOI

10.1200/JCO.2021.39.15_suppl.TPS597

Abstract #

TPS597

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Heather L. McArthur

First Author: Julia Foldi

First Author: Renske Kornalijnslijper-Altena

First Author: Rebecca Dent